Menu
Live News EQUITY M impact

Catalyst Pharma Files SEC Form

Catalyst Pharmaceuticals files preliminary proxy statement with SEC. The filing may indicate upcoming corporate actions or changes.

CPRX

Filed: 2026-05-28 AccNo: 0001193125-26-245426 Size: 2 MB